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Background: To systematically review the effects of interventions to improve exercise behaviour in sedentary people living with
and beyond cancer.
Methods: Only randomised controlled trials (RCTs) that compared an exercise intervention to a usual care comparison in
sedentary people with a homogeneous primary cancer diagnosis, over the age of 18 years were eligible. The following electronic
databases were searched: Cochrane Central Register of Controlled Trials MEDLINE; EMBASE; AMED; CINAHL; PsycINFO;
SportDiscus; PEDro from inception to August 2012.
Results: Fourteen trials were included in this review, involving a total of 648 participants. Just six trials incorporated prescriptions that
would meet current recommendations for aerobic exercise. However, none of the trials included in this review reported intervention
adherence of 75% or more for a set prescription that would meet current aerobic exercise guidelines. Despite uncertainty around
adherence in many of the included trials, the interventions caused improvements in aerobic exercise tolerance at 8–12 weeks
(SMD¼ 0.73, 95% CI¼ 0.51–0.95) in intervention participants compared with controls. At 6 months, aerobic exercise tolerance is also
improved (SMD¼ 0.70, 95% CI¼ 0.45–0.94), although four of the five trials had a high risk of bias; hence, caution is warranted in its
interpretation.
Conclusion: Expecting the majority of sedentary survivors to achieve the current exercise guidelines is likely to be unrealistic.
As with all well-designed exercise programmes, prescriptions should be designed around individual capabilities and frequency,
duration and intensity or sets, repetitions, intensity of resistance training should be generated on this basis.
It is estimated that there are now around 29 million people living
with or beyond cancer globally (excl. non-melanoma skin cancer)
(GLOBOCAN, 2008), and this number will continue to rise as a result
of an ageing population, increased detection and improving survival
(Maddams et al, 2009). For many cancer survivors, iatrogenic harm
caused by primary treatment, and the transition from end of treatment
to living beyond cancer, can have an impact on all aspects of life for the
individuals and their families (Ferrell et al, 1998).
Europe’s largest survey assessing patient-reported outcomes in
people living with and beyond cancer reported that o25% meet
the current physical activity guidelines, 43% have trouble with
fatigue and 45% experience fear of disease recurrence (Department
of Health—Quality Health, 2012). Furthermore, around 50% of
people with cancer have an existing chronic condition (Elliott et al,
2011) and are at an increased risk of developing new comorbidities
such as heart failure, coronary heart disease, osteoporosis and diabetes
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during the survivorship period (Khan et al, 2011). For these
individuals, the proportion suffering on-going poor health, quality
of life and disability may be as high as 25–30% (Elliott et al, 2011).
Exercise interventions for cancer survivors have received
increasing attention over the last decade as an effective way to
improve health-related quality of life, physical function and reduce
fatigue (Fong et al, 2012; Mishra et al, 2012a, b). Associations with
the reduced risk of disease recurrence have also come to
prominence (Holmes et al, 2005; Meyerhardt et al, 2006, 2009;
Kenfield et al, 2011; Richman et al, 2011). The current exercise
guidelines indicate that cancer survivors should achieve 150min
per week of aerobic exercise and twice weekly resistance (strength)
training (Rock et al, 2012). However, as few individuals achieve
such physical activity levels, a comprehensive review of behaviour-
change effectiveness including which interventions meet the current
guidelines is crucial. The aim of this study was to systematically
review the effects of exercise interventions on exercise behaviour in
sedentary people living with and beyond cancer.
MATERIALS AND METHODS
Search strategy. Full details of the MEDLINE search (which was
adapted accordingly for separate databases) can be seen in the
parallel publication of Bourke et al (2013). Briefly, the following
electronic databases were searched: Cochrane Central Register of
Controlled Trials MEDLINE; EMBASE; AMED; CINAHL;
PsycINFO; SportDiscus; PEDro from inception to August 2012.
To supplement this evidence, grey literature was evaluated, leading
experts in the field and charities were written to and reference lists
of other recent systematic reviews were screened for potential
trials.
Eligible studies. Only randomised controlled trials (RCTs)
involving adults (18 years or over) that aimed to improve exercise
behaviour compared with a usual care comparison group with a
sedentary lifestyle (i.e., not undertaking 30min or more of the
structured exercise of at least a moderate intensity, 3 days per
week) were included. Participants were required to have been
histologically or clinically diagnosed with cancer regardless of sex,
tumour site, tumour type, tumour stage and type of anticancer
treatment received. Only interventions that detailed the frequency,
duration and intensity of aerobic exercise behaviour, or the
frequency, intensity, type, sets, repetitions of resistance exercise
behaviour were included. The exercise programmes could be
individual or group, professionally led or not, and home,
community, primary care or exercise facility based. Eligible RCTs
must have included at least 6 weeks of follow-up.
In an effort to attempt to understand how different interven-
tions might be relevant to each type of cancer and its specific
treatment methods, we did not include studies of heterogeneous
cancer cohorts (i.e., patients with different primary cancer sites).
Studies in ‘at risk’ populations that are addressing primary
prevention research questions were not included. Trials directed
specifically at end-of-life-care pathways or hospital in-patients
were also excluded.
Study quality. Risk of bias and methodological quality were
assessed in accordance with the Cochrane Collaboration’s tool for
assessing risk of bias (Higgins and Green, 2011). Two review
authors (LB and KH) applied the risk of bias tool independently,
and any differences were resolved by discussion with a third review
author (ST or DR).
Outcomes. Primary outcomes were aerobic exercise behaviour
(frequency, duration and intensity) and resistance exercise
behaviour (sets, repetitions and intensity). Interventions were
judged as successful in achieving their exercise goals as identified in
the study methods if they reported at least 75% adherence over the
given follow-up period (Martin and Sinden, 2001). We also assessed
which interventions were designed to achieve the American Cancer
Society’s guidelines for exercise in people living with and beyond
cancer – that is aerobic exercise of at least 150min per week – with
at least 2 days per week of strength training (Rock et al, 2012).
Secondary outcomes were change in aerobic fitness
or exercise tolerance, change in skeletal muscle strength and
endurance, adverse events and intervention attrition rate.
Screening and data extraction. All titles and abstracts were
screened to identify studies that might meet the inclusion criteria
or that could not safely be excluded without full-text assessment
(e.g., where there is no abstract available) by two of the authors
working independently (LB and KH). Full texts were retrieved for
these articles. All eligible papers were formally abstracted by at least
two members of the group working independently (LB and KH)
using the data collection form and the risk of bias tool (Higgins and
Green, 2011). Any disagreements were resolved by discussion with
one more review author (ST or DJR).
Data synthesis. Data on adherence were quantified in terms of
number of prescribed exercise sessions attended as a proportion of
those prescribed. Interventions were categorised in terms of the
behaviour-change techniques (BCTs) used according to the
‘Coventry, Aberdeen & London—Refined’ (CALO-RE) taxonomy
by a health psychologist trained in using this taxonomy (LS) and
checked by LB (Michie et al, 2011). Where possible, and if
appropriate, meta-analyses of review outcomes were performed.
A fixed-effect model was used if there was no significant statistical
heterogeneity (I2X50%). For continuous outcomes (e.g., fitness or
exercise tolerance), the standardised mean difference between
treatment arms was estimated by extracting the final value and
standard deviation of the outcome of interest with the number of
participants assessed at follow-up. The Cochrane group RevMan
version 5.2 statistical analysis software was used to carry out meta-
analyses (Cochrane IMS, 2013).
RESULTS
We identified 5559 unique records from research database records
from grey literature and ‘snowballing’ techniques, which included
reference checking from recent large systematic reviews (see Figure 1,
PRISMA flow chart). Given that the detail of prescribed exercise
is rarely reported in manuscript abstracts (e.g., frequency,
intensity and duration of exercise prescription), this led to a large
number of manuscripts being evaluated at the full-text stage
(n¼ 402). After consensus agreement between study authors,
14 RCTs were included in this review (McKenzie and Kalda, 2003;
Pinto et al, 2003, 2005, 2013; Drouin et al, 2005; Kim et al, 2006;
Daley et al, 2007; Cadmus et al, 2009; Hayes et al, 2009; Perna et al,
2010; Kaltsatou et al, 2011; Bourke et al, 2011a, b; Musanti, 2012).
A total of 648 participants were randomised in these trials. A total
of 377 reports were excluded; reasons for exclusion were: non
RCTs – for example, reviews or comment/editorial articles; mixed
cancer cohorts or cohorts that included non-cancer populations;
trials that failed to describe essential metrics of exercise prescrip-
tion used in the intervention; trials involving active participants at
baseline; trials involving hospital in-patients; interventions that
were o6 weeks in follow-up; trials involving participants o18
years of age; not able to translate into English.
The majority of trials were conducted in breast cancer survivors
with only two trials in colorectal (Bourke et al, 2011b; Pinto et al,
2013) and one trial in prostate cancer (Bourke et al, 2011a). A
summary of study characteristics can be seen in Table 1. We only
found one study that reported data from patients with metastatic
disease (Bourke et al, 2011a) and two studies that were conducted
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in obese cohorts (Drouin et al, 2005; Cadmus et al, 2009). The
overwhelming proportions of participants were White, with only
one study reporting data from an ethnically diverse sample (Perna
et al, 2010). Comorbidities at baseline were largely unclear or
unreported, with only two studies (Daley et al, 2007; Hayes et al,
2009) reporting on proportion with lymphedema, and one trial
reporting on proportion with clinically relevant depression scores
(Perna et al, 2010).
Seven trials used a combination of supervised and non-
supervised exercises (Pinto et al, 2003; Kim et al, 2006; Cadmus
et al, 2009; Hayes et al, 2009; Perna et al, 2010; Bourke et al,
2011a, b); four trials were exclusively home-based (Drouin et al,
2005; Pinto et al, 2005, 2013; Musanti, 2012); and just three were
exclusively supervised trials (McKenzie and Kalda, 2003; Daley
et al, 2007; Kaltsatou et al, 2011). Contact with exercise
professionals or study researchers ranged from 20 times over 12
weeks (Hayes et al, 2009) to weekly phone calls after an initial one-
to-one exercise consultation (Pinto et al, 2005, 2013). Just six trials
incorporated prescriptions that would meet the Rock et al (2012)
recommendations for aerobic exercise, that is, 150min per week
(Cadmus et al, 2009; Pinto et al, 2013) or resistance exercise, that
is, strength training exercises at least 2 days per week (Perna et al,
2010; Bourke et al, 2011a, b; Musanti, 2012). Only three trials were
identified that attempted to objectively validate independent
exercise behaviour with accelerometers or heart rate monitoring
(Pinto et al, 2005, 2013; Cadmus et al, 2009). A summary of
included studies can be seen in Table 2.
Quality of studies. Three trials were judged not to include a high
risk of bias (Drouin et al, 2005; Cadmus et al, 2009; Bourke et al,
2011b). The majority of uncertainty in judging trial bias came from
a lack of clarity around randomisation procedures and blinding of
study outcome assessors (McKenzie and Kalda, 2003; Pinto et al,
2003, 2005, 2013; Kaltsatou et al, 2011). The majority of trials in
the review were judged to include at least one element indicating a
high risk of non-standard bias. These included adherence data
missing or not clear (McKenzie and Kalda, 2003; Hayes et al, 2009;
Kaltsatou et al, 2011; Musanti, 2012); high attrition at follow-up
(Pinto et al, 2003; Bourke et al, 2011a); significant differences in
those participants excluded from trial analysis/dropouts (Pinto
et al, 2003; Kim et al, 2006; Musanti, 2012); numbers randomised
to trial arms and trial completion rate are unclear (Perna et al,
2010); significant differences in cohorts at baseline (Pinto et al,
2003, 2005; Musanti, 2012); inconsistencies between objective and
subjective measures of exercise behaviour (Pinto et al, 2005, 2013).
Effects of the interventions. None of the trials included in this
review reported an adherence of 75% or more, to a prescription
that would meet the Rock et al (2012) aerobic exercise guidelines.
Only three trials reported an adherence of 75% or more to a lower
aerobic exercise goal (Cadmus et al, 2009; Bourke et al, 2011a, b).
Notably, all three incorporated both a supervised and independent
exercise component as part of their intervention and none placed
restrictions on the control group in terms of their exercise
behaviour. Cadmus et al (2009) appeared to be the most successful
Records identified through database
searching (n = 6358)
Cochrane Central (n =615)
MEDLINE (n =1181)
EMBASE (n =2633)
AMED (n =289)
CINAHL (n =309)
PsycINFO (n =658)
PEDro (n =507)
Sports Discus (n =166)
Sc
re
en
in
g 
In
cl
ud
ed
 
El
ig
ib
ilit
y 
Id
en
tif
ica
tio
n 
Additional records identified
through other sources (n =1308)
Trials registers (n =1301) 
Open grey dissertations (n =7)
Records after duplicates removed
(n =4827)
Records remaining after screening
by title and abstract (n =617)
Records
excluded
(n =4210)
Full-text articles assessed for
eligibility (n =402) 
Data base searches (n =245)
Other sources (n =157)
Studies not included (n =377)
Excluded studies (n =365) 
Awaiting classification (n =10)
Full-text unobtainable (n =2) 
Studies included in meta-analysis (n =7)
Included total n =14 (from 25 reports)
Primary tumours:
Breast cancer (n =11)
Prostate cancer (n =1)
Colo-rectal cancer (n =2)
Records after duplicates, ‘open’ and ‘in set-up’ trials
removed (n =581)
Records remaining after screening
by title and summary (n =68)
Records
excluded
(n =513)
Reference check of systematic
reviews ‘snowballing?’ (n =151)
Figure 1. PRISMA flow diagram of included and excluded studies.
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Table 1. Characteristics of included studies
Study
N and primary
cancer Current treatment
Exercise prescription
components
Method of measuring
exercise behaviour Instructions to controls
Cadmus et al, 2009 37, 38 (Intervention
vs control): BCa
Completed adjuvant
treatment (with the exception
of hormonal therapy) at least
6 months before enrolment.
57% vs 70% on hormone
therapy in the intervention
group vs controls; 30% on
tamoxifen in both arms; 27 vs
40% vs control on aromatase
inhibitors
Aerobic exercise.
Frequency: three sessions per
week supervised, two
sessions per week at home or
at a health club: total 5 days a
week. Duration: participants
were asked to perform three
15min sessions during week 1,
building to five 30min
moderate-intensity sessions
by week 5. Intensity: 60–80%
of maximal heart rate reserve
Heart rate monitors, physical
activity questionnaire, a
7day physical activity log,
and a 7day pedometer log.
Adherence to the
intervention among exercise
group participants was
assessed with 7day physical
activity logs weekly
Can exercise on their own if
they chose
Daley et al, 2007 34;36;38
(Intervention;
sham; control,
respectively): BCa
73.5%, 69.4%, 76.3% On
hormone therapy in the
intervention, sham, and usual
care groups, respectively
Aerobic exercise.
Frequency: three sessions per
week. Duration: 27min of
exercise on average
per session. Intensity: 65% to
85% of age-adjusted heart
rate maximum and RPE of
12–13
Adherence was calculated
from session attendance and
the amount (duration, RPE,
heart rate) of exercise
achieved by participants
during sessions was
calculated by extraction from
physical activity logs
Continue with lives as usual
Drouin et al, 2005 13 Intervention, 8
placebo stretching
controls: BCa
External beam radiation on
5 days per week for 7 weeks.
The affected breast and
regional lymph nodes
received a 4500 to 5000 cGy
dose in 200 cGy fractions with
a boost of 1000–1600 cGy
delivered to the primary
tumour bed
Aerobic exercise.
Frequency: three to five
times per week. Duration:
20–45min. Intensity: 50–70%
of the maximal heart rate
achieved by the participant
during a symptom-limited
graded exercise test
Participants were provided
with a training diary to
record. Participants in the
intervention group wore
heart rate monitors to record
training time and time spent
in the training heart rate
range to improve reporting of
data on exercise compliance,
training intensity and training
duration
Not to begin any new
exercise activity other than a
general flexibility
programme they were given
Kaltsatou et al,
2011
14,13 (Intervention
vs control): BCa
Treatment completed Aerobic exercise.
Frequency: three times per
week. Duration: the aerobic
training phase lasted 25min
and included learning and
practising Greek traditional
dances. Intensity: between
65 and 80% of maximum
heart rate or 13–14 on the
Borg scale.
Resistance exercise sets,
reps and intensity unclear
Unclear Refrain from any form of
recreational activity during
the study period
Kim et al, 2006 22,19 (Intervention
vs control): BCa
Chemotherapy was the most
common type of adjuvant
therapy (48.8%), followed by
radiotherapy (34.1%) and a
combination of
chemotherapy and
radiotherapy (17.1%)
Aerobic exercise.
Frequency: three days per
week. Duration: 30min of
aerobic exercise and five
minutes for warm-up or cool-
down. Intensity: moderate
intensity to produce an heart
rate corresponding to
60–70% of the individual’s
heart rate reserve and/or VO2
peak achieved on a graded
exercise test at baseline
Polar heart rate monitors and
a 7day physical activity log
Not to start any regular or
structured exercise
programme while
participating in the study
Pinto et al, 2003 12,12 (Intervention
vs control): BCa
Treatment completed Aerobic exercise.
Frequency: three times per
week. Duration: up to 30min.
Intensity: 60–70% of peak
heart rate by the end of the
12-week intervention
Attendance at supervised
exercise sessions
Not to change their current
level of physical activity
Pinto et al, 2005 43, 43 (Intervention
vs control): BCa
49% of intervention and 74%
of controls on hormone
therapy
Aerobic exercise.
Frequency: 2–5 days per
week. Duration: 10–30min.
Intensity: 55–65% of
maximum heart rate
The 7day physical activity
recall questionnaire and
accelerometer data providing
kcal h 1
Not to change their current
level of activity during the
first 12 weeks
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Table 1. ( Continued )
Study
N and primary
cancer Current treatment
Exercise prescription
components
Method of measuring
exercise behaviour Instructions to controls
Pinto et al, 2013 20, 26 (Intervention
vs control): CRCa
Treatment completed Aerobic exercise.
Frequency: two to five times
per week. Duration:
10–30min. Intensity: 64–76%
of estimated maximum heart
rate
The 7-day physical activity
recall questionnaire;
community healthy activities
model programme for seniors
questionnaire; stage of
motivational readiness for
physical activity.
Accelerometer data
Not to change their usual
level of activity
Bourke et al, 2011a 9, 9 (Intervention vs
control): CRCa
Treatment completed Aerobic exercise.
Frequency: three times or
more per week. Duration:
30min per session or more.
Intensity: 55–85% of age-
predicted maximum heart
rate/11–15 Borg scale.
Resistance exercise.
Frequency: three times per
week. Sets: between two and
four sets. Reps: eight to 12
reps. Resistance exercise
intensity: 60% of one rep max
Attendance at supervised
session with heart rate
monitors, exercise diaries and
Godin leisure score index
questionnaire
Continue current exercise/
dietary behaviours as
normal
Bourke et al, 2011b 25, 25 (Intervention
vs control): PCa
Undergoing androgen
suppression therapy for a
minimum of 6 months prior
Aerobic exercise.
Frequency: three times per
week. Duration: 30min
per session or more.
Intensity: 55–85% of age-
predicted maximum heart
rate/11–15 Borg scale.
Resistance exercise.
Frequency: three times per
week. Sets: between two and
four sets. Reps: eight to 12
reps. Intensity: 60% of 1 rep
max
Attendance at supervised
session with heart rate
monitors, exercise diaries and
Godin leisure score index
questionnaire
Continue current exercise/
dietary behaviours as
normal
Hayes et al, 2009 16, 16 (Intervention
vs control): BCa
Treatment completed Aerobic exercise.
Frequency: three to four or
more times per week.
Duration: 20–45þ min.
Intensity: three to seven on a
modified Borg scale.
Resistance exercise sets
unclear
Exercise adherence rates and
qualitative comments were
used to provide insight into
the acceptability of the
programme
Continue habitual activities
McKenzie and
Kalda, 2003
7,7 (Intervention vs
control): BCa
Treatment completed Aerobic exercise.
Frequency: 3 days per week
(initiated after week 2).
Duration: 5–20min. Intensity:
arm cycling at a resistance of
8.3–25W. Intensity was also
assessed with Polar HR
monitors. A target heart rate
was 60–80% of maximum
predicted by age.
Resistance exercise intensity
unclear
Work in kJ was calculated for
each session for every
subject, and this was used to
calculate cumulative work
performed over the course of
the programme
Not to initiate any new
activity
Musanti, 2012 Flexibility group
(n¼ 13); aerobic
group (n¼ 12)
resistance group
(n¼ 17), aerobic
and resistance
group (n¼ 13): BCa
Hormonal therapy could be
on-going: 56% on hormone
therapy
Aerobic exercise.
Frequency: three to five
times per week. Duration:
15–30min. Intensity: 40–65%
of the calculated maximum
heart rate.
Resistance exercise.
Frequency: 2/3 times per
week reps: 10–12. Resistance
exercise sets: one. Intensity:
rating of perceived exertion
of three to eight, on a scale of
one to 10
Adherence to the exercise
prescription was calculated as
a proportion of completed
sessions over the total
possible number of sessions
in their assigned exercise
programme
All participants were
prescribed flexibility
exercise and received a
written guidebook that
included general
information about exercise
participation, an
individualised exercise
prescription, exercise
instructions and an exercise
log sheet
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study regarding the promotion of aerobic exercise behaviour, with
75% of the intervention group reporting between 90 and 119min
per week of moderate intensity exercise, at an average heart rate of
76% of predicted maximum, for 6 months. However, of these three
trials, only two (Bourke et al, 2011a, b) met the Rock et al (2012)
exercise guidelines: specifically, two to four sets of resistance
exercise at 60% of one rep maximum, for eight to 12 reps, was
carried out twice per week, for just 6 weeks. These three trials
shared the following BCTs: goal setting, self-monitoring of
behaviour and prompting practice, which were common to most
of the interventions, included in the review; however, additionally
these three studies included generalisation of a target behaviour –
that is, getting people to engage in exercise outside of the
immediate intervention environment.
These trials did not explicitly state a theoretical basis. Other
studies such as Daley et al (2007) or Perna et al (2010) were much
more comprehensive in their reporting of BCTs and were based on
recognised behaviour-change theory. Full details of intervention
coding according to the CALO-RE taxonomy (Michie et al, 2011)
of exercise BCTs can be seen in Table 3. Several trials might have
achieved an adherence of 75% or more; however, because of
unclear reporting it was not possible to make a judgement on
whether this criterion had been fulfilled.
A meta-analysis of change in aerobic exercise tolerance was
carried out on seven trials that reported these outcomes. Aerobic
exercise tolerance was significantly better after 8–12 weeks of
follow-up in intervention vs control in 330 participants
(SMD¼ 0.73, 95% CI¼ 0.51–0.95) and at 6 months of follow-up
in intervention vs control in 271 participants (SMD¼ 0.70, 95%
CI¼ 0.45, 0.94; see Figure 2). The 6-month data should be viewed
with caution as four of the five trials were judged to have a
high risk of bias. Limb strength was significantly better in
intervention vs controls in 91 participants (SMD¼ 0.51, 95%
CI¼ 0.09–0.93). After removing one trial for a high risk of bias
(Musanti, 2012), in 68 participants the moderate effect size was
still apparent but was no longer significant (SMD¼ 0.47, 95%
CI¼  0.01, 0.96).
Attrition rates during the intervention from the included trials
ranged from 25% (Pinto et al, 2003) to 0% (Drouin et al, 2005)
(median 6%), with five trials not clearly reporting attrition in the
intervention arm. Eight trials reported adverse events that ranged
from minor – for example, muscular–skeletal problems (Musanti,
2012) to major events – for example, death (Kim et al, 2006).
However, only one study was explicit as to which of these adverse
events were caused by participating in the intervention group (two
instances of plantar fasciitis; Cadmus et al, 2009).
DISCUSSION
The review findings indicate that currently there is a lack of
convincing evidence to suggest that existing exercise interventions
are useful for achieving the Rock et al (2012) guidelines of 150min
per week of aerobic exercise and twice per week of resistance
exercise, in sedentary cancer cohorts. Adherence to exercise
interventions, which is crucial for understanding treatment dose,
is frequently poorly reported. Importantly, the fundamental
metrics of exercise behaviour, that is, frequency, intensity and
duration, or repetitions, sets and intensity of resistance training,
although easy to devise and report, are seldom included in
published clinical trials. Attempting to reproduce any exercise
prescription without detailing these metrics is fraught with
problems, and most likely not possible. The extent of exclusion
at the full-text screening stage (377 publications excluded from
402) provided the first indication of problems associated with
quality of reporting in this research field.
The supportive evidence that we have narratively synthesised
suggests that interventions that combine the supervision of exercise
training in tandem with a requirement of independent exercise are
likely to promote better adherence. Use of generalisation of
behaviour was also a common and relatively unique feature of
interventions, which reported better adherence.
Despite the uncertainty around adherence in many of the
included trials, the interventions caused improvements in aerobic
exercise tolerance at 8–12 weeks and 6 months of follow-up.
Such improvements could be interpreted as reassuring: some of
the doubts around adherence might only extend to reporting issues
rather than real problems with fidelity. Alternatively, this result
could have arisen from the rapid, relatively large early gains in
function expected in sedentary participants from exercise training,
which could mask smaller changes in non-adherers. Further,
aerobic exercise tolerance should not be considered as definitive
evidence of changes in aerobic fitness (with the accompanying
spectrum of underlying physiological adaptation). It could simply
reflect individuals becoming accustomed to the feeling of exertion
from exercise testing and a better tolerance towards perceptions of
fatigue.
To the authors’ knowledge, this is the first comprehensive
review to evaluate RCTs with respect to their success in improving
exercise behaviour in sedentary cancer cohorts against state of the
art recommendations for these patients. The large majority of these
trials included women with breast cancer, the remaining three were
in people with prostate and colorectal cancer. Furthermore, the
Table 1. ( Continued )
Study
N and primary
cancer Current treatment
Exercise prescription
components
Method of measuring
exercise behaviour Instructions to controls
Perna et al, 2010 51 Participants in
total. Numbers
randomised to
each arm are
unclear: BCa
The majority (52.9%) of
women had stage I breast
cancer and received
lumpectomy surgery (74.1%).
Many (44.1%) women
received both radiation and
chemotherapy, 26.5%
received radiation only, 8.8%
received chemotherapy only,
and 20.6% received no
adjuvant therapy
Aerobic exercise.
Frequency: three or more
times per week. Duration:
15–45min. Intensity: 50–85%
of maximum predicted heart
rate or 11–16 on the Borg
scale.
Resistance exercise.
Frequency: three times per
week. Sets: one to two sets.
Resistance exercise reps:
12–15. Participant body
weight was used for lower
body exercises
Participants were provided
with monthly calendars to
record their exercise activity
and were contacted weekly
by telephone or electronic
mail according to patient
preference. Godin leisure
score index and the leisure
time exercise questionnaire
self-report instrument surveys
were also used
Women in the information
control group received a
45min session covering
their fitness, strength and
flexibility assessment results
and an informational
brochure
Abbreviations: BCa¼breast cancer; CRCa¼ colorectal cancer; PCa¼prostate cancer; Reps¼ repetitions; RPE¼ rate of perceived exertion.
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Table 2. Summary of study exercise behaviour
Study
Exercise
components
Meets Rock
et al guidelines? Adherence summary
At least 75%
adherence? High risk of bias?
Change in
AET reported? Adverse event rate
Cadmus et al, 2009 Aerobic 33% Reported
150min per week
of moderate
intensity aerobic
exercise at an
average of 76% Hr,
for 6 months
75% Of women were
doing between 90 and
119min of moderate-
intensity aerobic activity
per week at 6 months
Yes: for up to
119min per
week
No No Five of the 37 women
randomised to
exercise experienced
an adverse event; 2
events were related
to the study (plantar
fasciitis)
Daley et al, 2007 Aerobic No 77% Of the exercise
therapy attended 70%
(at least 17 of 24
sessions) or more of
sessions
Unclear Yes: outcome
assessors were not
blinded to
participants’ group
allocation
Yes Three withdrawals in
the intervention
group: unclear as to
why this was. Some
withdrawals due to
medical
complications in
placebo and control
arms but unclear if
study related
Drouin et al, 2005 Aerobic Unclear Participants in the
intervention group
averaged 3.6 days per
week of aerobic exercise
over an 8-week period
Unclear No Yes None reported
Kaltsatou et al, 2011 Aerobic Unclear Not reported Not reported Yes: method of
measuring exercise
and adherence not
reported
No None reported
Kim et al, 2006 Aerobic No The average weekly
frequency of exercise
was 2.4±0.6 sessions
and the average
duration of exercise
within prescribed target
Hr was 27.8±8.1min
per session. The overall
adherence was
78.3±20.1%
Yes Yes: data missing for
45% of the cohort
Yes Reasons for
withdrawal included
personal problems
(n¼ 2), problems at
home (n¼2),
problems related to
chemotherapy (n¼ 3),
thrombophlebitis in
the lower leg (n¼ 2),
non-exercise-related
injuries (n¼ 1), or
death (n¼ 1). Unclear
which arm of the trial
these date relate to
Pinto et al, 2003 Aerobic Unclear Subjects attended a
mean of 88% of the 36
session supervised
exercise programme
Yes Yes: 38% lost to
follow-up. Exercise
tolerance test
performed but no
control group
comparison data
were reported
Yes Not reported. It is
unclear why the six
controls dropped out
Pinto et al, 2005 Aerobic Unclear At week 12, intervention
participants reported a
mean of 128.53min per
week of moderate
intensity exercise.
However, no changes
were reported in the
accelerometer data in
the intervention group
(change
score¼  0.33 kcal h 1)
Less than 75%
of the
intervention
group were
meeting the
prescribed goal
after week 4
Yes: significantly
more control group
participants were on
hormone treatment.
Accelerometer data
do not support the
self-reported
physical activity
behaviour
Yes Not clear if chest pain
was related to
exercise in drop out
whose participation
was terminated
Pinto et al, 2013 Aerobic 3-Day PAR
questionnaire
indicates that
64.7% of the
intervention group
and 40.9% of
controls were
achieving the
guidelines at 3
months
Correlation between
self-reported moderate
intensity exercise and
accelerometer data at
the 3 months follow-up,
where the only
significant between
group change is
reported: r¼ 0.32
No Yes: accelerometer
data not reported:
also cited correlation
was weak (0.32).
Further, there was
substantial
contamination in the
control group
Yes One cancer
recurrence in the
control group at 3
months
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overwhelming majority of participants were White, with only one
trial made up of an ethnically diverse population. As such, other
ethnicities are substantially under-represented. Thirteen of the 14
included trials were conducted in North America or Western
Europe, with one trial from Australia. All were in high-income
nations. No evidence was found from low- or middle-income
countries, and it is uncertain whether the featured interventions
would be deliverable in these parts of the world.
Another recent systematic review that examined predictors of
adherence to exercise in people living with and beyond cancer
(Husebo et al, 2013) found that the transtheoretical model of
behaviour change and the theory of planned behaviour were
significantly associated with better exercise adherence. The current
review does not explicitly support such conclusions. It should be
noted that there are key differences in each review methodology,
with the present review only including RCTs and people who were
sedentary at baseline. Other recent systematic reviews have focused
on the potential health-related outcomes of exercise interventions
for people living with and beyond cancer. In this respect, Fong et al
(2012) similarly reported improvements in aerobic exercise
Table 2. ( Continued )
Study
Exercise
components
Meets Rock
et al guidelines? Adherence summary
At least 75%
adherence? High risk of bias?
Change in
AET reported? Adverse event rate
Bourke et al, 2011a Aerobic and
resistance
6 Weeks of
resistance exercise
at twice a week
90% Attendance at the
supervised sessions.
94% of the independent
exercise sessions were
completed
Yes No Yes One stroke in the
intervention group,
unrelated to the
exercise programme
Bourke et al, 2011b Aerobic and
resistance
6 Weeks of
resistance exercise
at twice a week.
95% Attendance at the
supervised exercise
sessions. Compliance to
the self-directed
exercise aspect of the
lifestyle intervention was
87%
Yes Yes: high dropout
rate at the post
intervention 6 month
follow-up
assessment
Yes Two men in the
intervention arm were
discontinued due to
cardiac complications
before the 12week
assessments. Two
more reported
muscular–skeletal
complaints before the
6month assessment.
Five men reported
various health
problems in the
control group
prohibiting them
attending the
6month assessment
Hayes et al, 2009 Aerobic and
resistance
Unclear The majority of women
(88%) allocated to the
intervention group
participated in 70% or
more of scheduled
supervised exercise
sessions
Unclear Yes: adherence data
on unsupervised
aspect of the
intervention is not
clear
No None reported
McKenzie and
Kalda, 2003
Aerobic and
resistance
No Unclear Unclear Yes: adherence to
exercise not
reported
No None reported
Musanti 2012 Aerobic and
resistance
12 Weeks of
resistance exercise
at twice or three
times per week
Mean percentage
adherence were as
follows: flexibility¼ 85%,
aerobic¼ 81%,
resistance¼ 91%, and
aerobic plus
resistance¼ 86%
Unclear Yes: a significant
number of the
dropouts belonged
to the resistance
exercise group
(n¼ 8/13). Only 50%
of activity logs
returned
Yes There were adverse
events reported in
two women during
the study. In both
cases, the women
developed tendinitis:
one in the shoulder
and the other in the
foot. Both had
histories of tendonitis,
and both received
standard treatment
Perna et al, 2010 Aerobic and
resistance
Three months of
resistance exercise
at three times per
week
Women assigned to the
structured intervention
completed an average
of 83% of their
scheduled hospital-
based exercise sessions,
(only 4 weeks in
duration) and 76.9%
completed all 12
sessions. Home-based
component (8 weeks in
duration not clear)
Unclear Yes: numbers
randomised to
intervention and
control groups are
unclear as are
numbers completing
in each arm
No Unclear
Abbreviations: AET¼ aerobic exercise tolerance, Hr¼ heart rate, PAR¼physical activity recall.
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Table 3. CALO-RE taxonomy of behaviour-change techniques
Behaviour change
technique
Bourke
et al,
2011a
Bourke
et al,
2011b
Cadmus
et al,
2009
Daley
et al,
2007
Drouin
et al,
2005
Hayes
et al,
2009
Kaltsatou
et al,
2011
McKenzie
and
Kalda,
2003
Musanti,
2012
Perna
et al,
2010
Kim
et al,
2006
Pinto
et al,
2003
Pinto
et al,
2005
Pinto
et al,
2013
Theory TTM EXSEM TTM TTM
TTM
SCT
Provide Info on
consequences of behaviour
in general
X X X X
Provide Info on
consequences of behaviour
to the individual
Provide Info about others
approval
Provide normative info
about others behaviour
Programme set goal X X X X X X X X X X X X X X
Goal-setting (behaviour) X X X X X X
Goal setting (outcome)
Action planning
Barrier identification/
problem solving
X X X X X X
Set graded tasks X X X X X X X X X
Prompt review of
behavioural goals
X X
Prompt review of outcome
goals
Prompt rewards contingent
on effort or progress
towards goal
X X X
Provide rewards contingent
on successful behaviour
X
Shaping
Prompting generalisation
of a target behaviour
X X X X X
Prompt self-monitoring of
behaviour
X X X X X X X X X X
Prompt self-monitoring of
behavioural outcome
X X X X X X
Prompting focus on past
success
X
Provide feedback on
performance
X X X X
Provide information on
where and when to perform
behaviour
X X
Provide instruction on how
to perform the behaviour
X X X X X X X X X X
Model/demonstrate the
behaviour
X X X
Teach to use prompts/cues X X X
Environmental restructuring X X
Agree behavioural contract X
Prompt practice X X X X X X X X X X X X X X
Use of follow-up prompts X X
Facilitate social comparison
Plan social support/social
change
X X X
Prompt identification as
role model/position
advocate
Prompt anticipated regret
Fear arousal
Prompt self-talk
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tolerance and muscle strength. One substantial difference in the
methodology of the present review when compared with other
Cochrane reviews in the area (Mishra et al, 2012a, b) is that we
only included studies where the essential metrics of exercise
behaviour are reported.
There are limitations to this review, namely the large majority of
these trials included women with breast cancer. One trial involved
men with advanced prostate cancer and two trials involved
colorectal cancer survivors. Although these three primary cancers
make up the majority of the population living with and beyond
cancer, other common cancers such as lymphoma and lung cancer
do not appear at all in this review. Less common cancers are also
not represented in the evidence base. Furthermore, the over-
whelming majority of participants were White, with only one trial
made up of an ethnically diverse population.
Recently, in the largest survey of cancer survivors (covering
multiple cancer types) to be conducted in Europe (N¼ 3300), the
UK Department of Health reported that o25% of people living
with and beyond cancer are achieving 30min of exercise on 5 or
more days per week. (Department of Health—Quality Health,
2012) This is a clear indicator that the overwhelming majority of
cancer survivors are not active. It is therefore of critical importance
that future research is designed to improve exercise behaviour in
sedentary individuals living with or beyond cancer, particularly in
under-represented groups. All trials should report as standard,
frequency, intensity and duration of aerobic exercise, as well as
reps, sets and intensity of resistance exercise used in intervention
prescriptions. Using these essential metrics of exercise prescription
will not only help to achieve a balance between
safe yet effective exercise but will also ensure that meaningful
re-evaluation over time can be undertaken, as adaptation or disease
progression dictates.
Reporting of adherence as a single proportion of the cohort who
attended/performed exercise according to the set prescription and
reporting of BCTs (e.g., using the CALO-RE taxonomy) needs to
be standardised. By achieving these standardisations, oncology
Table 3. ( Continued )
Behaviour change
technique
Bourke
et al,
2011a
Bourke
et al,
2011b
Cadmus
et al,
2009
Daley
et al,
2007
Drouin
et al,
2005
Hayes
et al,
2009
Kaltsatou
et al,
2011
McKenzie
and
Kalda,
2003
Musanti,
2012
Perna
et al,
2010
Kim
et al,
2006
Pinto
et al,
2003
Pinto
et al,
2005
Pinto
et al,
2013
Theory TTM EXSEM TTM TTM
TTM
SCT
Prompt use of imagery
Relapse prevention/coping
planning
X X
Stress management/
emotional control training
X
Motivational interviewing
Time management
General communication
skills training
Stimulate anticipation of
future rewards
Abbreviations: EXSEM¼Exercise Self-Esteem Model; SCT¼ Social cognitive theory; TTM¼Transtheoretical model.
Experimental
Study or subgroup
Bourke, 2011a 528.2 114.5
125
4.4
369.4
4.1
2.1
5.327.7
–16.3
24.7
35
1810.1
495.8
9 9
25
33
19
12
43
264.7
2.2
4.3
351.5
5.1
129.2
376.7
379.8
31.5
1630.4
23
–17.9
23.720
163 0.73 [0.51, 0.95]
–2
167
43
11
22
33
25
125.7 4.8 1.20 [0.18, 2.22]
0.90 [0.31, 1.48]
0.73 [0.23, 1.23]
0.49 [–0.14, 1.11]
0.39 [–0.44, 1.22]
0.74 [0.30, 1.17]
0.79 [0.18, 1.40]
Favours (control) Favours (experimental)
13.7
100.0
26.3
7.4
12.9
20.2
14.8Bourke, 2011b
Daley, 2007a
Kim, 2006
Musanti, 2012
Pinto, 2005
Pinto, 2013
Total (95% CI)
Heterogeneity: χ2=2.40, df=6 (P=0.88); I 2=0%
Test for overall effect: Z=6.38 (P<0.00001)
Control
s.d.Mean Total s.d.Mean Total Weight, %
Std. mean difference Std. mean difference
435.8
33.8
483.3
–16.79
28.4 5.5
1.7
85.9
4.8
118.5 25
31
14
43
20 24.4
403.1
30.5
351 114.4
71.9
4
1.6
5 26
138
43
13
31
25 18.5
22.9
9.4
32.7
16.6
100.0 0.70 [0.45, 0.94]
0.75 [0.15, 1.36]
0.55 [0.12, 0.98]
0.98 [0.17, 1.78]
0.74 [0.22, 1.25]
0.72 [0.14, 1.29]
–17.71
133
–2 –1
Favours (control) Favours (experimental)
Bourke, 2011b
Daley, 2007a
Kaltsatou, 2011
Pinto, 2005
Pinto, 2013
Total (95% CI)
Heterogeneity: χ2=0.96, df=4 (P=0.92); I 2=0%
Test for overall effect: Z=5.55 (P  < 0.00001)
Experimental
Study or subgroup
Control
Mean s.d. Total Mean s.d. Total Weight, %
Std. mean difference Std. mean difference
IV, fiexd, 95% CI IV, fiexd, 95% CI
IV, fiexd, 95% CIIV, fiexd, 95% CI
0 1 2
210–1
Figure 2. Meta-analysis of (A) aerobic exercise tolerance at 8–12 weeks of follow-up and (B) aerobic exercise tolerance at 6 months of follow-up.
Note, in all meta-analysis data from Pinto et al (2005) has been multiplied by 1 to control for direction of effect (that is, lower values in
a timed test indicate a better outcome). Data were extracted from the combined aerobic and resistance training arm of Musanti (2012).
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scientists and clinicians will help to bring the discipline up to the
level of acceptable rigour that will help to elucidate dose response
of exercise interventions for given health outcomes. This should
afford an opportunity to communicate achievable exercise
recommendations for sedentary people living with and beyond
cancer.
DISCLAIMER
This review received no external funding.
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